COVID-19 ETIOLOGIYALI POLINEVROPATIYASI BO‘LGAN BEMORLARDA KLINIK VA NEVROLOGIK ASORATLARNI O‘RGANISH NATIJALARI
Maqola yon paneli
Maqolaning asosiy mazmuni
Abstrak
Koronavirus kasalligi (COVID-19) SARS-CoV-2 virusi keltirib chiqaradigan yuqumli kasallikdir. COVID-19 bilan kasallanganlarning aksariyati yengil va o‘rtacha darajadagi alomatlarni boshdan kechiradi va maxsus davolashsiz tuzalib ketadi. Biroq, ba’zilari jiddiy kasal bo‘lib, tibbiy yordamga muhtoj bo‘ladi. 2019-2020 yillardagi koronavirus pandemiyasi nafaqat yangi yuqumli agentning yuqori tajovuzkorligini, balki uning yurak-qon tomir tizimiga jiddiy asoratlarni keltirib chiqarish qobiliyatini ham ko‘rsatdi. Koronavirus infektsiyasi davrida nafaqat o‘pka, balki boshqa nevrologik asoratlar ham rivojlanishi mumkin. Ba’zi odamlarda COVID infektsiyasidan haftalar va oylar o‘tgach sodir bo‘lgan ba’zi alomatlar periferik asab tizimi, markaziy asab tizimi (miya va orqa miya) va tananing boshqa barcha qismlari o‘rtasida signallarni yuboradigan keng aloqa tarmog‘i buzilganligini ko‘rsatadi. Maqsad: Koronavirus etiologiyasining polinevopatiyasi bo‘lgan bemorlarning klinik va nevrologik xususiyatlarini baholash. Usullari: Tadqiqotga polinevopatiyasi bo‘lgan 62 bemor, koronavirus kasalligi bilan og‘rigan 32 polinevopatiyali bemorning asosiy guruhi va polinevopatiyasi bo‘lgan 30 bemor ishtirok etdi. Natijalar: Tadqiqotga qo‘shilish vaqtida bemorlarning shikoyatlarida asosiy guruhdagi bemorlarning 97 foizida va taqqoslash guruhining 95 foizida hissiy buzilishlar, uyqusizlik, zaiflik va ish faoliyatini pasaytirish belgilari ustunlik qildi. Xulosa: O‘tkazilgan klinik va nevrologik tahlillar shuni ko‘rsatadiki, polineyropatiya bilan koronavirus kasalligi bilan og‘riganidan keyin nevrologik alomatlar kuchayadi va bemorlarni joriy etish va kompleks davolash uchun maqsadli taktika talab qiladi.
Maqola tafsilotlari
Bo'lim
Ushbu asar Creative Commons Attribution 4.0 International litsenziyasi asosida litsenziyalangan.
Qanday iqtibos keltirish kerak
Adabiyotlar
Вознюк И.А., Ильина О.М., Коломенцев С.В Ишемический инсульт как клиническая форма и патогенетическая модель в структуре поражения центральной нервной системы при COVID-19. Вестник восстановительной медицины,- Ne 4 (98). 2020, - C.90-98
Bhatraju PK, Ghassemieh BJ, Nichols M, et al. Covid-19 in critically ill patients in the Seattle region—case series. N Engl J Med. 2020;382(21):2012–2022.
Bocci T, Campiglio L, Zardoni M, et al. Critical illness neuropathy in severe COVID- 19: a case series. Neurol Sci. 2021;42(12):4893-4898.
Helms J, Kremer S, Merdji H, et al. Neurologic features in severe SARS-CoV-2 infection. N Engl J Med. 2020:382(23):2268-2270. doi: 10.1056/NEJMc2008597PubMedGoogle Scholar
Peric S, Stulnig TM. Diabetes and COVID-19: disease-management-people. Wien Klin Wochenschr. 2020;132(13-14):356–361.
Sanyaolu A, Okorie C, Marinkovic A, et al. Comorbidity and its impact on patients with COVID-19. SN Compr Clin Med. 2020;2(8):1069–1076.
Shi S, Qin M, Shen B, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020;200950. do:10.1001/jamacar dio.2020.0950ArticlePubMedGoogle Scholar
Treister R, Lodahl M, Lang M, Tworoger SS, Sawilowsky S, Oaklander AL. Initial development and validation of a patient-reported symptom survey for small-fiber polyneuropathy. J Pain. 2017;18(5):556-563.
World Health Organization. Coronavirus (COVID-2019) situation reports. Accessed June 15, 2020. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports/.
World Health Organization A Clinical Case Definition of Post COVID-19 Condition by a Delphi Consensus. 2021. Accessed October 1, 2021. WHO/2019-nCoV/Post_COVID- 19_condition/Clinical_case_definition/2021.1.Google Scholar